Senior M&A Partner Frank Aquila authored the introduction to the 2024 edition of Chambers and Partners: Healthcare M&A. In his introduction, Frank reviews trends seen throughout the healthcare M&A industry in 2023 and offers an upbeat outlook for 2024 following a robust start to the year.
Topics covered in the introduction include the resurgence of mega deals and financial distress–driven healthcare services consolidation. Frank also discusses factors in favor of healthcare M&A heading into 2024, such as recent improvements in economic outlook, updates to patent policy, product innovation, increased access to capital and shifts in Medicare fees.
“Despite decade-low activity for global M&A, driven by recession threats, steep interest rate hikes, geopolitical tensions and market uncertainty, the healthcare industry stood out as one of the key sectors driving M&A in 2023,” Frank writes.